Quinoline, naphthalene and conformationally constrained...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 215/227 (2006.01) A61K 31/47 (2006.01) A61K 31/4709 (2006.01) A61K 31/473 (2006.01) A61K 31/4745 (2006.01) A61K 31/495 (2006.01) A61P 31/04 (2006.01) A61P 31/06 (2006.01) C07D 215/38 (2006.01) C07D 295/096 (2006.01) C07D 401/04 (2006.01) C07D 401/06 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 405/12 (2006.01) C07D 471/04 (2006.01)

Patent

CA 2711912

The invention relates to a compound of general formula I, II, III, IV, V, VI, VII, VIII, IX, X or a tautomer and the stereochemically isomeric forms thereof or pharmaceutically acceptable salts thereof, a N-oxide form thereof or a pro-drug thereof. The compound is usable as a medicament for the treatment of mycobacterial disease.

La présente invention concerne un composé de formule générale I, II, III, IV, V, VI, VII, VIII, IX, X ou un tautomère et les formes isomères sur le plan stéréochimique de ce composé ou des sels pharmaceutiquement acceptables, une forme de N-oxyde ou un précurseur de ce composé. Le composé peut être utilisé en tant que médicament pour le traitement de maladies mycobactériennes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Quinoline, naphthalene and conformationally constrained... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinoline, naphthalene and conformationally constrained..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline, naphthalene and conformationally constrained... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1469788

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.